Give the board the whole proposition to assess

I want a board to understand the resources and responsibilities inside the growth recommendation it receives. Income is an important part of the account, but a proposition can also change the amount outstanding, the length of the commitment, the economic concentration and the risk the company accepts. Those consequences should shape the choice before the strategic headline is settled. My executive experience concerns bringing them into one recommendation while respecting the professional owners who assess financing, credit and contractual terms.

The longer-duration case exposed an omission in my own recommendation. I had supported a broad extension using projected additional income before rebuilding the funded amount. Finance's challenge led to an explicit comparison and a withdrawal of that support. I would bring the willingness to change a view into board work, not claim that a corrected model proves I can predict an outcome. Directors need to know whether the assumptions still support the proposed commitment and whether management has allowed a material correction to change the plan.

The concentration case asks a different question about the account. Twenty-four legal buyers did not establish twenty-four independent economic exposures. Risk colleagues assessed the relationships and set the relevant ceiling. The revised strategy lost ₹45 crore of proposed volume. I would expect the board paper to carry that reduction into its totals rather than preserve the original opportunity through a reassuring customer count. The board's task is to examine the strategic meaning of the assessed exposure, without becoming an informal credit-approval body outside the company's established authority.

A portfolio purchase also needs a clear statement of recommendation maturity. Our assessment separated disputed invoices, agreed credit notes and the remainder without calling that remainder certified collectible. Additional review cost ₹18 lakh and the transaction remained conditional. That is an outcome worth reporting accurately. A board should understand what further evidence could change the decision, who needs to assess it and when more investigation stops being useful. Neither a discount nor an extended process supplies the missing judgement by itself.

I would also ask how the financing horizon relates to the business commitment. A familiar rolling relationship may support an expectation of renewal without providing the same conditions as a longer committed arrangement. The difference can carry a real cost. In the fictional expansion comparison, a simple annual interest illustration was useful but not the entire facility price. Treasury, finance and legal owners retained the actual assessment. Directors should see the assumptions and limits clearly enough to decide on the strategy they support, rather than mistake the cheapest percentage for a complete funding answer.

As a first-time director, I would need to learn the receiving company's full business and duties. I have presented to directors through the CEO but have not held a statutory seat. My preferred contribution would be through strategy or risk discussion alongside experienced colleagues with complementary expertise. I would begin with induction and committee responsibilities rather than assume that an executive title establishes readiness to chair. Oversight also requires attention to subjects beyond my familiar models and a willingness to support a collective conclusion different from my initial recommendation.

Independence, confidentiality and capacity need a specific assessment. Relationships through Qavrethi's ownership, borrowers, funding providers and transaction counterparties may intersect with another company's agenda. Relevant links and personal interests should be disclosed before confidential engagement, with qualified advice on applicable requirements. Recusal may be appropriate in some circumstances and insufficient in others. I would not transfer private portfolio findings or funding terms to make an outside contribution appear better evidenced. The experience belongs in my questions; another organisation's confidential records do not.

The fictional preparation position is registration with the IICA databank in April 2026, an unfinished proficiency assessment and no claimed exemption. Twenty-four days is a provisional allowance, not an unconditional commitment, and must include induction, papers, travel and exceptional work alongside the executive role. I would seek employer consent and a clear reason for the proposed contribution. The purpose of the next step is to help directors assess the whole proposition with honesty about its demands, including when the appropriate strategic answer is smaller, costlier or still unfinished.